Arborgen Holdings Ltd

Arborgen Holdings Ltd has a debt-to-equity ratio of 0.26 and a current ratio of 4.07, indicating a relatively strong liquidity position despite a negative net cash position after subtracting total debt. The company's liquidity is assessed as medium, with free cash flow of -19,000,000 USD and operating cash flow of 2,700,000 USD. Profitability metrics show a return on equity of -0.1726 and a return on assets of -0.1225, indicating significant underperformance relative to industry norms. The company reported a net loss of 21,500,000 USD and an operating loss of 20,800,000 USD, with a gross profit of 18,200,000 USD on revenue of 63,200,000 USD. Arborgen operates through a single forestry genetics segment, with revenue concentrated in the United States South and Brazil. The company has a production capacity of 450 million seedlings annually and serves over 2,000 customers. It is also engaged in carbon markets and protocol development for plantation forestry. The company's growth trajectory is mixed, with a reported revenue of 63,200,000 USD and an analyst estimate of 111,071,000 USD. Capital expenditures of 7,800,000 USD and a free cash flow of -19,000,000 USD suggest ongoing investment and operational challenges. Risk factors include a medium liquidity risk and a low dilution risk. The company has a total equity of 124,600,000 USD and total liabilities of 50,900,000 USD, with long-term debt of 32,600,000 USD. The risk assessment highlights the negative net cash position as a key flag. Recent events include the company's engagement with carbon registries and carbon companies, as well as its participation in protocol development for plantation forestry. The company's operations in Brazil and the United States South are central to its strategy.